Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

 

Enter Stock Symbol:  

Aimmune Therap Cmn (AIMT)

21.71 +0.09 (+0.42%)

7/20/2017  4:00pm

Open:

21.76

Pre. Close:

21.62

High:

21.93

Low:

21.47

Volume:

155,518

Market Cap:

1.09B

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

22.28 - 22.41

22.41 - 22.56

Low:

20.92 - 21.03

21.03 - 21.16

Close:

21.36 - 21.66

21.66 - 22.04

Technical analysis  (as of: 2017-07-20 4:34:20 PM)

Overall:

      

Stoxline posted a NEUTRAL today, same as yesterday. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next Buy or SELL signal.

Target:

Six months: 25.65     One year: 29.96

Support:

Support1: 18.43    Support2: 16.25

Resistance:

Resistance1: 21.96    Resistance2: 25.65

Pivot:

21.14

Moving Averages:

MA(5): 21.62     MA(20): 21.02

MA(100): 20.06     MA(250): 18.95

MACD:

MACD(12,26): 0.70     Signal(12,26,9): 0.68

%K %D:

%K(14,3): 84.84     %D(3): 87.09

RSI:

RSI(14): 63.92

52-Week:

High: 27.31  Low: 11.21  Change(%): 85.2

Average Vol(K):

3-Month: 29737  10-Days 11219

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
AIMT has closed below upper band by 17.5%. Bollinger Bands are 35.4% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Wed, 14 Jun 2017 21:22:51 GMT
Aimmune Therapeutics, Inc. (NASDAQ:AIMT) Insider Mary M. Rozenman Sells 45060 ...

Wed, 11 Jan 2017 14:30:08 GMT
2017: A Transformational Year For Aimmune Therapeutics

Thu, 20 Jul 2017 05:15:00 GMT
Positive Chaikin Money Flow Spotted in Aimmune Therapeutics Inc (AIMT)

Fri, 04 Nov 2016 11:00:34 GMT
Aimmune Therapeutics Announces $145 Million Equity Investment by Nestlé Health ...

Wed, 15 Mar 2017 17:26:15 GMT
Aimmune Therapeutics' (AIMT) CEO Dr. Stephen Dilly on Q4 2016 Results ...

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

NA

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Specialty Advanced Pharmaceuticals

Shares Out. (M)

50.34

Shares Float (M)

26.49

% Held by Insiders

23.89

% Held by Institutions

3.00

Shares Short (K)

4260

Shares Short Prior Month (K)

4330

Stock Financials

EPS

-2.030

EPS Est. Current Year

-2.660

EPS Est. Next Year

-3.270

EPS Est. Next Quarter

-0.710

Forward EPS

-3.272

Book Value (p.s.)

5.260

PEG Ratio

0.18

Profit Margin

Operating Margin

Return on Assets (ttm)

-24.2

Return on Equity (ttm)

-39.8

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-1.820

Qtrly Earnings Growth

Operating Cash Flow (M)

-68.14

Levered Free Cash Flow (M)

-43.57

FoxReading.com

Valuation

P/E

-10.69

P/E Growth Ratio

P/BV

4.13

P/S

P/CF

-16.04

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.